Serotonin receptors represents highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

Psychopharmacology

Volumn 174, Issue 1, 2004, Pages 17-24

  Roth, Bryan L ^a   Hanizavareh, S Mohammad ^a   Blum, Andrew E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT 6; 5 HT1A; 5 HT2A; 5 HT4; Cognition; Schizophrenia; Serotonin

Indexed keywords

1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 (1 BUTYL 4 PIPERIDINYL) 1 PROPANONE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; AC 90179; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; AMISULPRIDE; ARIPIPRAZOLE; ATROPINE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DIZOCILPINE; HALOPERIDOL; METOCLOPRAMIDE; NEUROLEPTIC AGENT; OLANZAPINE; PSILOCYBINE; RISPERIDONE; RIVASTIGMINE; RS 17017; SALCATONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 4 AGONIST; SEROTONIN 6 ANTAGONIST; SEROTONIN 6 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; SL 65 0155; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BINDING AFFINITY; CLINICAL TRIAL; COGNITIVE DEFECT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG POTENCY; GASTROINTESTINAL DISEASE; HALLUCINATION; HUMAN; LOW DRUG DOSE; MEMORY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SIDE EFFECT; ANIMAL; CLASSIFICATION; COGNITION; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIPSYCHOTIC AGENTS; COGNITION; HUMANS; MEMORY; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SEROTONIN AGENTS;

EID: 3142704173     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Aghajanian GK, Marek GJ (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36:589-599
2. 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40:399-412
3. Azmitia EC (2001) Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull 56:413-424
4. 1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 14:35-46
5. 1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res 959:58-67
6. Balschun D, Wolfer DP, Gass P, Mantamadiotis T, Welzl H, Schutz G, Frey JU, Lipp HP (2003) Does cAMP response element-binding protein have a pivotal role in hippocampal synaptic plasticity and hippocampus-dependent memory? J Neurosci 23:6304-6314
7. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function [In Process Citation]. Neuropharmacology 38:1083-1152
8. 6 receptor antagonist, Ro 04-6790, in rats. Br J Pharmacol 126:1537-1542
9. 4 receptor activation on GABA release from guinea pig hippocampal slices. Neuroreport 13:2177-2180
10. Boast C, Bartolomeo AC, Morris H, Moyer JA (1999) 5HT antagonists attenuate MK801-impaired radial arm maze performance in rats. Neurobiol Learn Mem 71:259-271
11. Bonaventure P, Hall H, Gommeren W, Cras P, Langlois X, Jurzak M, Leysen JE (2000) Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain. Synapse 36:35-46
12. 6 receptors in nigro-striatal function in rodents. Br J Pharmacol 125:1562-1566
13. Buchanan R, Summerfelt A, Tek C, Gold J (2003) An open-labeled trial of adjunctive donepezil for cognitive impairment in patients with schizophrenia. Schizophr Res 59:29-33
14. 2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist-than dopamine agonist-induced hyperactivity in mice. J Neural Transm 106:123-129
15. Chen A, Muzzio IA, Malleret G, Bartsch D, Verbitsky M, Pavlidis P, Yonan AL, Vronskaya S, Grody MB, Cepeda I, Gilliam TC, Kandel ER (2003) Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an Inhibitor of ATF4 (CREB-2) and C/EBP proteins. Neuron 39:655-669
16. Conn PJ, Sanders-Bush E (1984) Selective 5-HT2 antagonists inhibit serotonin-stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacology 23:993-996
17. Dawson LA, Nguyen HQ, Li P (2000) In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 130:23-26
18. Fillion G, Rousselle JC, Goiny M, Pradelles P, Dray F, Jacob J (1977) [5-hydroxytryptamine-sensitive adenylate cyclase activity in brain synaptosomal membrane preparations]. C R Acad Sci Hebd Seances Acad Sci D 285:265-268
19. Fink H, Morgenstern R, Oelssner W (1984) Clozapine - a serotonin antagonist? Phamacol Biochem Behav 20:513-517
20. Gaddum JH, Hameed KA (1954) Drugs which antagonize 5-hydroxytryptamine. Br J Pharmacol 9:240-248
21. 2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505-2511
22. Green MF, Braff DL (2001) Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications. Biol Psychiatry 49:374-384
23. Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull 26:119-136
24. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G (1994) One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 151:1409-1416
25. Jacobs BL, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165-229
26. Jakab R, Goldman-Rakic P (1998) 5-hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 95:735-740
27. Kamm MA (2002) Review article: the complexity of drug development for irritable bowel syndrome. Aliment Pharmacol Ther 16:343-351
28. 6 serotonin receptor. J Neurochem 66:47-56
29. Kraepelin E (1919) Dementia praecox and paraphrenia. re-issued by Thoemmes Continuum, Dorset, UK
30. Kroeze WK, Kristiansen K, Roth BL (2002) Molecular biology of serotonin receptors structure and function at the molecular level. Curr Top Med Chem 2:507-528
31. 4 receptors. Neuropharmacology 41:844-853
32. 4 receptors, enhances place and object recognition in young adult and old rats. Prog Neuropsychopharmacol Biol Psychiatry 27:185-195
33. Leucht S, Wahlbeck K, Hamann J, Kissling W (2003) New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 361:1581-1589
34. 6 receptor antagonists in rodent models of learning. J Pharmacol Exp Ther (in press)
35. 4 receptors. Neuropharmacology 36:697-706
36. Martin-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, Artigas F (2001) Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci 21:9856-9866
37. Meltzer HY, McGurk SR (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233-255
38. Meltzer HY, Park S, Kessler R (1999) Cognition, schizophrenia, and the atypical antipsychotic drugs. Proc Natl Acad Sci USA 96:13591-13593
39. Meneses A (2002) Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism? Cell Mol Neurobiol 22:675-688
40. Minabe Y, Hashimoto K, Watanabe KI, Ashby CR, Jr. (2001) Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study. Synapse 40:102-112
41. Moser PC, Bergis OE, Jegham S, Lochead A, Duconseille E, Terranova JP, Caille D, Berque-Bestel I, Lezoualc'h F, Fischmeister R, Dumuis A, Bockaert J, George P, Soubrie P, Scatton B (2002) SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties. J Pharmacol Exp Ther 302:731-741
42. 35S]GTPgammaS binding study. Eur J Pharmacol 355:245-256
43. Nocjar C, Roth BL, Pehek EA (2002) Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience 111:163-176
44. Pehek EA, McFarlane HG, Maguschak K, Price B, Pluto CP (2001) M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res 888:51-59
45. Potkin SG, Shipley J, Bera R, Carreon D, Fallon J, Alva G, Keator D (2001) Clinical and PET effects of M100907, a selective 5HT-2A receptor antagonist. Schizophr Res 49:242
46. 2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study. Eur Neuropsychopharmacol 13:123-128
47. 6 receptor. Synapse 47:218-224
48. Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN (2001) Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92:179-212
49. Renyi L, Evenden JL, Fowler CJ, Jerning E, Kelder D, Lake-Bakaar D, Larsson LG, Mohell N, Sallemark M, Ross SB (2001) The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran- 5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist. J Pharmacol Exp Ther 299:883-893
50. 2 receptors. Eur J Pharmacol 89:325-326
51. 6 receptor antagonist. J Med Chem 46:1273-1276
52. 4 receptor regulates secretion of non-amyloidogenic precursor protein. J Biol Chem 276:44881-44888
53. Rodriguez JJ, Garcia DR, Pickel VM (1999) Subcellular distribution of 5-hydroxytryptamine2A and N-methyl-D-aspartate receptors within single neurons in rat motor and limbic striatum. J Comp Neurol 413:219-231
54. Rodriguez JJ, Doherty MD, Pickel VM (2000) N-methyl-D-aspartate (NMDA) receptors in the ventral tegmental area: subcellular distribution and colocalization with 5-hydroxytryptamine(2A) receptors. J Neurosci Res 60:202-211
55. Roth BL (1994) Multiple serotonin receptors: clinical and experimantal aspects. Ann Clin Psychiatr 6:67-78
56. Roth BL, Nakaki T, Chuang DM, Costa E (1984) Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacology 23:1223-1225
57. Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ, Jr., Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268:1403-1410
58. 2A receptors in atypical antipsychotic drug actions. Neuroscientist 5:254-262
59. Roth BL, Lopez E, Patel S, Kroeze W (2000) Multiplicity of serotonin receptors: useless diverse molecules or an embarrassment of riches? Neuroscientist 6:252-262
60. Roth BL, Sheffler DJ, Potkin S (2003) Atypical antipsychotic drugs: unitary or multiple mechanisms for "atypicality". Clin Neurosci Res 3:108-117
61. 1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer s disease. Curr Pharm Des 8:139-145
62. Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124:57-73
63. Schroeder JA, Wolfe WM, Thomas MH, Tsueda K, Heine MF, Loyd GE, Vogel RL, Hood GA (1994) The effect of intravenous ranitidine and metoclopramide on behavior, cognitive function, and affect. Anesth Analg 78:359-364
64. Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Roth BL, Mailman R (2003) Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28:1400-1411
65. 4 receptor modulation of acetylcholine outflow in guinea pig brain slices. Neuroreport 10:547-551
66. 6 receptor: localization and function. Ann N Y Acad Sci 861:91-96
67. Sumiyoshi T, Matsui M, Nohara S, Yamashita I, Kurachi M, Sumiyoshi C, Jayathilake K, Meltzer HY (2001a) Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. Am J Psychiatry 158:1722-1725
68. Sumiyoshi T, Matsui M, Yamashita I, Nohara S, Kurachi M, Uehara T, Sumiyoshi S, Sumiyoshi C, Meltzer HY (2001b) The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia. Biol Psychiatry 49:861-868
69. 4 receptor agonist, RS 17017. Psychopharmacology 135:407-415
70. 2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology 28:170-181
71. 2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology 20:311-321
72. Velligan DI, Miller AL (1999) Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment. J Clin Psychiatry 60 Suppl 23:25-28
73. Velligan DI, Bow-Thomas CC, Mahurin RK, Miller AL, Halgunseth LC (2000) Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? J Nerv Ment Dis 188:518-524
74. 4 receptor mRNA in rat brain by in situ hybridization histochemistry. Brain Res Mol Brain Res 43:356-60
75. 4 receptor variants. Neuropharmacology 42:60-73
76. Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Babler A, Vogel H, Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9:3897-3902
77. Ward RP, Hamblin MW, Lachowicz JE, Hoffman BJ, Sibley DR, Dorsa DM (1995) Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience 64:1105-1111
78. 2A receptor inverse agonists as antipsychotics. J Pharmacol Exp Ther 299:268-276
79. 2A receptors in working memory. J Neurosci 22:2843-2854
80. 2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27:79-82
81. 2A receptors in vitro and in vivo. Neuroscience 91:599-606
82. Wilson MA, Molliver ME (1991a) The organization of serotonergic projections to cerebral cortex in primates: regional distribution of axon terminals. Neuroscience 44:537-53
83. Wilson MA, Molliver ME (1991b) The organization of serotonergic projections to cerebral cortex in primates: retrograde transport studies. Neuroscience 44:555-570
84. Winstanley CA, Chudasama Y, Dalley JW, Theobald DE, Glennon JC, Robbins TW (2003) Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology 167:304-314
85. Wooley D, Shaw E (1954) A biochemical and pharmacological suggestion about certain mental disorders. Proc Natl Acad Sci U S A 40:228-231
86. 6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41:210-219
87. 2A serotonin receptors regulates receptor trafficking and signal transduction. J Biol Chem 278:21901-21908
88. 2A serotonin receptors in cortical pyramidal neurons in vitro. Neuroscience (in press)
89. 1A receptors on human explicit memory. Am J Psychiatry 160:334-340